Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

CD40-targeted peptide proposed for type 1 diabetes therapy lacks relevant binding affinity to its cognate receptor. Reply to Pagni PP, Wolf A, Lo Conte M et al [letter].

Vaitaitis GM, Olmstead MH, Waid DM, Carter JR, Wagner DH Jr.

Diabetologia. 2019 Sep;62(9):1730-1731. doi: 10.1007/s00125-019-4945-7. Epub 2019 Jul 8. No abstract available.

PMID:
31286154
2.

Biomarker discovery in pre-Type 1 Diabetes; Th40 cells as a predictive risk factor.

Vaitaitis GM, Rihanek M, Alkanani AK, Waid DM, Gottlieb PA, Wagner DH; Type 1 Diabetes TrialNet Study Group.

J Clin Endocrinol Metab. 2019 May 7. pii: jc.2019-00364. doi: 10.1210/jc.2019-00364. [Epub ahead of print]

PMID:
31063181
3.

A CD40 targeting peptide prevents severe symptoms in experimental autoimmune encephalomyelitis.

Vaitaitis GM, Yussman MG, Wagner DH Jr.

J Neuroimmunol. 2019 Jul 15;332:8-15. doi: 10.1016/j.jneuroim.2019.03.013. Epub 2019 Mar 21.

PMID:
30925295
4.

Are we aiming to miss in translational autoimmunity treatments?

Vaitaitis GM, Wagner DH.

Version 2. F1000Res. 2018 Nov 6 [revised 2019 Jan 1];7:1754. doi: 10.12688/f1000research.16894.2. eCollection 2018.

5.

Challenges to Reshape the Future of Type 1 Diabetes Research.

Bleich D, Wagner DH.

J Clin Endocrinol Metab. 2018 Aug 1;103(8):2838-2842. doi: 10.1210/jc.2018-00568. Review.

6.

Overlooked Mechanisms in Type 1 Diabetes Etiology: How Unique Costimulatory Molecules Contribute to Diabetogenesis.

Wagner DH Jr.

Front Endocrinol (Lausanne). 2017 Aug 23;8:208. doi: 10.3389/fendo.2017.00208. eCollection 2017. Review.

7.

CD40-mediated signalling influences trafficking, T-cell receptor expression, and T-cell pathogenesis, in the NOD model of type 1 diabetes.

Vaitaitis GM, Waid DM, Yussman MG, Wagner DH Jr.

Immunology. 2017 Oct;152(2):243-254. doi: 10.1111/imm.12761. Epub 2017 Jun 19.

8.

Th40 cells (CD4+CD40+ Tcells) drive a more severe form of Experimental Autoimmune Encephalomyelitis than conventional CD4 T cells.

Vaitaitis GM, Yussman MG, Waid DM, Wagner DH Jr.

PLoS One. 2017 Feb 13;12(2):e0172037. doi: 10.1371/journal.pone.0172037. eCollection 2017.

9.
10.

Resolving the bulk ion region of millimeter-wave collective Thomson scattering spectra at ASDEX Upgrade.

Stejner M, Nielsen S, Jacobsen AS, Korsholm SB, Leipold F, Meo F, Michelsen PK, Moseev D, Rasmussen J, Salewski M, Schubert M, Stober J, Wagner DH; ASDEX Upgrade Team.

Rev Sci Instrum. 2014 Sep;85(9):093504. doi: 10.1063/1.4894199.

PMID:
25273723
11.

A CD40-targeted peptide controls and reverses type 1 diabetes in NOD mice.

Vaitaitis GM, Olmstead MH, Waid DM, Carter JR, Wagner DH Jr.

Diabetologia. 2014 Nov;57(11):2366-73. doi: 10.1007/s00125-014-3342-5. Epub 2014 Aug 8.

12.

Pro-inflammatory T-lymphocytes rapidly infiltrate into the brain and contribute to neuronal injury following cardiac arrest and cardiopulmonary resuscitation.

Deng G, Carter J, Traystman RJ, Wagner DH, Herson PS.

J Neuroimmunol. 2014 Sep 15;274(1-2):132-40. doi: 10.1016/j.jneuroim.2014.07.009. Epub 2014 Jul 22.

13.

Defining a new biomarker for the autoimmune component of Multiple Sclerosis: Th40 cells.

Waid DM, Schreiner T, Vaitaitis G, Carter JR, Corboy JR, Wagner DH Jr.

J Neuroimmunol. 2014 May 15;270(1-2):75-85. doi: 10.1016/j.jneuroim.2014.03.009. Epub 2014 Mar 15.

14.

CD40 interacts directly with RAG1 and RAG2 in autoaggressive T cells and Fas prevents CD40-induced RAG expression.

Vaitaitis GM, Wagner DH Jr.

Cell Mol Immunol. 2013 Nov;10(6):483-9. doi: 10.1038/cmi.2013.24. Epub 2013 Sep 16.

15.

An alternative role for Foxp3 as an effector T cell regulator controlled through CD40.

Vaitaitis GM, Carter JR, Waid DM, Olmstead MH, Wagner DH Jr.

J Immunol. 2013 Jul 15;191(2):717-25. doi: 10.4049/jimmunol.1300625. Epub 2013 Jun 17.

16.

Dysfunctional resident lung mesenchymal stem cells contribute to pulmonary microvascular remodeling.

Chow K, Fessel JP, Kaoriihida-Stansbury, Schmidt EP, Gaskill C, Alvarez D, Graham B, Harrison DG, Wagner DH Jr, Nozik-Grayck E, West JD, Klemm DJ, Majka SM.

Pulm Circ. 2013 Jan;3(1):31-49. doi: 10.4103/2045-8932.109912.

17.

The specific antigen approach in multiple sclerosis: can it ever be enough?

Wagner DH Jr.

Clin Immunol. 2012 Aug;144(2):139-41. doi: 10.1016/j.clim.2012.06.001. Epub 2012 Jun 12. No abstract available.

PMID:
22729132
18.

Galectin-9 controls CD40 signaling through a Tim-3 independent mechanism and redirects the cytokine profile of pathogenic T cells in autoimmunity.

Vaitaitis GM, Wagner DH Jr.

PLoS One. 2012;7(6):e38708. doi: 10.1371/journal.pone.0038708. Epub 2012 Jun 7.

19.

CD40 engagement of CD4+ CD40+ T cells in a neo-self antigen disease model ablates CTLA-4 expression and indirectly impacts tolerance.

Carter J, Vaitaitis GM, Waid DM, Wagner DH Jr.

Eur J Immunol. 2012 Feb;42(2):424-35. doi: 10.1002/eji.201141880.

20.

Isolation & characterization of Hoechst(low) CD45(negative) mouse lung mesenchymal stem cells.

Chow KS, Jun D, Helm KM, Wagner DH, Majka SM.

J Vis Exp. 2011 Oct 26;(56):e3159. doi: 10.3791/3159.

21.

The pathology of bleomycin-induced fibrosis is associated with loss of resident lung mesenchymal stem cells that regulate effector T-cell proliferation.

Jun D, Garat C, West J, Thorn N, Chow K, Cleaver T, Sullivan T, Torchia EC, Childs C, Shade T, Tadjali M, Lara A, Nozik-Grayck E, Malkoski S, Sorrentino B, Meyrick B, Klemm D, Rojas M, Wagner DH Jr, Majka SM.

Stem Cells. 2011 Apr;29(4):725-35. doi: 10.1002/stem.604.

22.

CD40 glycoforms and TNF-receptors 1 and 2 in the formation of CD40 receptor(s) in autoimmunity.

Vaitaitis GM, Wagner DH Jr.

Mol Immunol. 2010 Aug;47(14):2303-13. doi: 10.1016/j.molimm.2010.05.288. Epub 2010 Jun 19.

23.

The co-evolution of our understanding of CD40 and inflammation.

Wagner DH Jr.

Diabetologia. 2009 Jun;52(6):997-9. doi: 10.1007/s00125-009-1357-0. Epub 2009 Apr 10. No abstract available.

PMID:
19360393
24.

CD40 on NOD CD4 T cells contributes to their activation and pathogenicity.

Baker RL, Wagner DH Jr, Haskins K.

J Autoimmun. 2008 Dec;31(4):385-92. doi: 10.1016/j.jaut.2008.09.001. Epub 2008 Oct 31.

PMID:
18951762
25.

Disruption of the homeostatic balance between autoaggressive (CD4+CD40+) and regulatory (CD4+CD25+FoxP3+) T cells promotes diabetes.

Waid DM, Vaitaitis GM, Pennock ND, Wagner DH Jr.

J Leukoc Biol. 2008 Aug;84(2):431-9. doi: 10.1189/jlb.1207857. Epub 2008 May 9.

26.
27.

An analytical workflow for investigating cytokine profiles.

Siebert JC, Inokuma M, Waid DM, Pennock ND, Vaitaitis GM, Disis ML, Dunne JF, Wagner DH Jr, Maecker HT.

Cytometry A. 2008 Apr;73(4):289-98. doi: 10.1002/cyto.a.20509.

28.

A unique T cell subset described as CD4loCD40+ T cells (TCD40) in human type 1 diabetes.

Waid DM, Wagner RJ, Putnam A, Vaitaitis GM, Pennock ND, Calverley DC, Gottlieb P, Wagner DH Jr.

Clin Immunol. 2007 Aug;124(2):138-48. Epub 2007 Jun 8.

PMID:
17560173
29.

Re-shaping the T cell repertoire: TCR editing and TCR revision for good and for bad.

Wagner DH Jr.

Clin Immunol. 2007 Apr;123(1):1-6. Epub 2006 Sep 20. Review.

PMID:
16990051
30.

Peripheral CD4loCD40+ auto-aggressive T cell expansion during insulin-dependent diabetes mellitus.

Waid DM, Vaitaitis GM, Wagner DH Jr.

Eur J Immunol. 2004 May;34(5):1488-97.

31.
32.

Expression of CD40 identifies a unique pathogenic T cell population in type 1 diabetes.

Wagner DH Jr, Vaitaitis G, Sanderson R, Poulin M, Dobbs C, Haskins K.

Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3782-7. Epub 2002 Mar 12.

33.
34.

gamma delta+ T cells regulate major histocompatibility complex class II(IA and IE)-dependent susceptibility to coxsackievirus B3-induced autoimmune myocarditis.

Huber SA, Stone JE, Wagner DH Jr, Kupperman J, Pfeiffer L, David C, O'Brien RL, Davis GS, Newell MK.

J Virol. 1999 Jul;73(7):5630-6.

35.

IL-4 and IL-10 modulation of CD40-mediated signaling of monocyte IL-1beta synthesis and rescue from apoptosis.

Poe JC, Wagner DH Jr, Miller RW, Stout RD, Suttles J.

J Immunol. 1997 Jul 15;159(2):846-52.

PMID:
9218603
36.

Rescue of thymocytes from glucocorticoid-induced cell death mediated by CD28/CTLA-4 costimulatory interactions with B7-1/B7-2.

Wagner DH Jr, Hagman J, Linsley PS, Hodsdon W, Freed JH, Newell MK.

J Exp Med. 1996 Nov 1;184(5):1631-8.

37.
38.

Abnormal protein translocation as the elusive cause of cystic fibrosis: an hypothesis.

Herd JK, Wagner DH, LeClair IO.

Med Hypotheses. 1990 Mar;31(3):177-87. Review.

PMID:
2189062
40.

Identifying the right nurse manager. An objective selection process.

Johnson EP, Wagner DH, Sweeney JP.

J Nurs Adm. 1984 Nov;14(11):24-30.

PMID:
6567659
41.

Columbia river gorge.

Topik C, Wagner DH, Cook SA, Udovic JD, Frank PW.

Science. 1982 Feb 12;215(4534):745. No abstract available.

PMID:
17747829
42.
43.

Metabolism of thiofanox in cotton plants.

Holm RE, Chin WT, Wagner DH, Stallard DE.

J Agric Food Chem. 1975 Nov-Dec;23(6):1056-60. No abstract available.

PMID:
1194563
44.

Care of the patient with infectious neuronitis.

Stanton JH, Hendrickson FL, Wagner DH.

Nurs Clin North Am. 1966 Sep;1(3):503-10. No abstract available.

PMID:
5178297
45.

The function of the parathyroid glands and their disturbances.

WAGNER DH.

Surg Clin North Am. 1962 Feb;42:171-83. No abstract available.

PMID:
14004333
46.

The management of nodular goiters.

WAGNER DH.

Chic Med. 1961 Jul 22;64:7-10. No abstract available.

PMID:
13782474
47.

The preparation and care of diabetic patients requiring surgery.

WAGNER DH.

Surg Clin North Am. 1959 Feb;39(1):161-70. No abstract available.

PMID:
13625089
48.

Errors in the choice of abdominal wall incisions and in their closure.

WAGNER DH.

Surg Clin North Am. 1958 Feb;38(1):175-81. No abstract available.

PMID:
13556526
49.

Intestinal intubation; techniques, safeguards, complications.

WAGNER DH.

Surg Clin North Am. 1955 Feb:151-7. No abstract available.

PMID:
13238202
50.

Pyloric stenosis in twins.

WAGNER DH, BARATZ J.

AMA Am J Dis Child. 1951 Feb;81(2):253-5. No abstract available.

PMID:
14798967

Supplemental Content

Loading ...
Support Center